Staurosporine promotes endothelial cell assembly and fak phosphorylation during in vitro angiogenesis

Journal of Cardiovascular Pharmacology

Volumn 45, Issue 1, 2005, Pages 22-29

  Tarzami, Sima T ^a   Hsieh, Susie Shao Hsu ^a   Esterman, Michail A ^a   Jai, Pal Singh ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Angiogenesis; FAK phosphorylation; Staurosporine

Indexed keywords

ALPHA2 INTEGRIN; FOCAL ADHESION KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RAF PROTEIN; STAUROSPORINE; VASCULOTROPIN; VITRONECTIN RECEPTOR;

ADDITION REACTION; ANGIOGENESIS; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL CORD;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FOCAL ADHESION KINASE 2; HUMANS; INTEGRIN ALPHA2; INTEGRIN ALPHAVBETA3; MICROSCOPY, CONFOCAL; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-RAF; STAUROSPORINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 11144345046     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200501000-00005     Document Type: Article

References (46)

1. Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987;235:442-447.
2. Vukanovic J, Passaniti A, Hirata T, et al. Antiangiogenic effects of the quinoline-3-carboxamide linomide. Can Res. 1993;53:1833-1837.
3. Schumacher B, Stegmann TH, Pecher P. The stimulation of neoangiogenesis in the ischemic human heart by the growth factor FGF: First clinical results. J Cardiovasc Surg. 1998;39:783-789.
4. Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nature Med. 1999;5:1359-1364.
5. Helisch A, Ware A. Therapeutic angiogenesis in ischemic heart disease. Thromb Haemostas. 1999;82:772-780.
6. Majesky MW. A little VEGF goes a long way: Therapeutic angiogenesis by direct injection of vascular endothelial growth factor-encoding plasmid DNA. Circulation. 1996;94:3062-3064.
7. Tsurumi Y, Takeshita S, Chen D, et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation. 1996;94:3281-3290.
8. Magovern CJ, Mack CA, Zhang J, et al. Regional angiogenesis induced in non-ischemic tissue by an adenoviral vector expressing vascular endothelial growth factor. Hum Gene Ther. 1997;8:215-227.
9. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996; 380:435-439.
10. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439-442.
11. Ferrara N, Houck KA, Jakeman LB, et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev. 1992;13:18-32.
12. Aiello LP, Bursell S, Clermont A, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective β-isoform-selective inhibitor. Diabetes. 1997;46:1473-1480.
13. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
14. Alon T, Hemo I, Itin A, et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med. 1995;1:1024-1028.
15. Kroll J, Waltenberger J. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem. 1997;272:32521-32527.
16. Zachary I. Vascular endothelial growth factor: How it transmits its signal. Exp Nephrol. 1998;6:480-487.
17. Takahashi T, Ueno H, Shibuya M. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene. 1999;18:2221-2230.
18. Rakusan K. Coronary angiogenesis. From morphometery to molecular biology and back. Ann NY Acad Sci. 1995;752:257-266.
19. Grant DS, Kleinman HK, Martin GR. The role of basement membranes in vascular development. Ann NY Acad Sci. 1990;588:61-72.
20. Grant DS, Lelkes PI, Fukuda K, et al. Intracellular mechanisms involved in basement membrane induced blood vessel differentiation in vitro. In Vitro Cell Dev Biol. 1991;27A:327-336.
21. Cid M, Grant DS, Hoffman GS, et al. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest. 1993;91:977-985.
22. Boudreau N, Andrews C, Srebrow A, et al. Induction of the angiogenic phenotype by Hox D3. J Cell Biol. 1997;139:257-264.
23. Babaei S, Teichert-Kuliszewska K, Monge J, et al. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res. 1998;82:1007-1015.
24. Folkman J, Haudenschild C. Angiogenesis in vitro. Nature. 1980;288: 551-556.
25. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, et al. Neuropeptide Y: A novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res. 1998;83:187-195.
26. Xia P, Aiello LP, Ishii H, et al. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest. 1996;98:2018-2026.
27. Tarzami ST, Cheng R, Miao W, et al. Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death. J Mol Cell Cardiol. 2002;34:209-221.
28. Hauck CR, Hsia DA, Schlaepfer DD. Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells. J Biol Chem. 2000;275:41092-41099.
29. Eliceiri BP, Puente XS, Hood JD, et al. Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling. J Cell Biol. 2002;157:149-160.
30. Hsia DA, Mitra SK, Hauck CR, et al. Differential regulation of cell motility and invasion by FAK. J Cell Biol. 2003;160:753-767.
31. Gliki G, Wheeler-Jones C, Zachary I. Vascular endothelial growth factor induces protein kinase C (PKC)-independent Akt/PKB activation and phosphatidylinositol 3′-kinase-mediates PKC delta phosphorylotion: role of PKC in angiogenesis. Cell Biol Int. 2002;26:751-759.
32. Salazar EP, Rozengurt E. Src family kinases are required for integrin-mediated but not for G protein-coupled receptor stimulation of focal adhesion kinase autophosphorylation at Tyr-397. J Biol Chem. 2001;276: 17788-17795.
33. Cobb BS, Schaller MD, Leu TH, et al. Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK. Mol Cell Biol. 1994;14:147-155.
34. Chen HC, Guan JL. Stimulation of phosphatidylinositol 3′-kinase association with focal adhesion kinase by platelet-derived growth factor. J Biol Chem. 1994;269:31229-31233.
35. Polte TR, Hanks SK. Interaction between focal adhesion kinase and Trk-associated tyrosine kinase substrate p130Cas. Proc Natl Acad Sci USA. 1995;92:10678-10682.
36. Panetti TS. Tyrosine phosphorylation of paxillin, FAK, and p130CAS: effects on cell spreading and migration. Front Biosci. 2002;7:d143-150.
37. Shen TL, Guan JL. Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI3K, Grb7 and Grb2 in focal contacts. FEBS Lett. 2001;499:176-181.
38. Friedlander M, Brooks PC, Shaffer RW, et al. Definition of two angiogenic pathways by distinct alpha v integrins. Science. 1995;270:1500-1502.
39. Lewis JM, Cheresh DA, Schwartz MA. Protein kinase C regulates alpha v beta 5-dependent cytoskeletal associations and focal adhesion kinase phosphorylation. J Cell Biol. 1996;134:1323-1332.
40. Swannie HC, Kaye SB. Protein kinase C inhibitors. Curr Oncol Rep. 2002;4:37-46.
41. Gescher A. Staurosporine analogues - pharmacological toys or useful antitumor agents? Crit Rev Oncol Hematol 2000;34:127-135.
42. Rasouly D, Rahamim E, Lester D, et al. Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition. Mol Pharmacol. 1992;42:35-43.
43. Yamamoto S, Jiang H, Nishikawa K, et al. Protein kinase C-dependent and -independent actions of a potent protein kinase C inhibitor, staurosporine. Eur J Pharmacol. 1992;227:113-122.
44. Shea TB, Beerman ML. Staurosporine induced morphological differentiation of human neuroblastoma cells. Cell Biol Int Rep. 1991;15:161-168.
45. Sowa G and Przewlocki R. Ouabain enhances the lipopolysaccharide-induced nitric oxide production by rat peritoneal macrophages. Immunopharmacology. 1997;36:95-100.
46. Young MR, Liu SW, Meisinger J. Protein phosphatase-2A restricts migration of Lewis lung carcinoma cells by modulating thephosphorylation of focal adhesion proteins. Int J Cancer. 2003;103:38-44.